Random peptide library displayed on AAV vectors targeting human primary coronary artery endothelial cells
Research output: Patents › Patent
Standard
WIPO - Weltorganisation für geistiges Eigentum. Patent No.: WO 2004083441. Sept 30, 2004.
Research output: Patents › Patent
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - PAT
T1 - Random peptide library displayed on AAV vectors targeting human primary coronary artery endothelial cells
AU - Kleinschmidt, Jürgen
AU - Müller, Oliver
AU - Trepel, Martin
AU - Kaul, Felix
AU - Leder, Christoph
PY - 2004/9/30
Y1 - 2004/9/30
N2 - Described is a method of producing a repertoire of random peptides on the surface of AAV particles wherein said random peptides are expressed as a fusion with an AAV capsid protein of an AAV particle which displays at its surface said random polypeptides. Also described is a peptide library obtainable by said method as well as a method of selecting a gene therapy vector specific for a desired cell type comprising the steps of (a) infecting the desired cell type with a peptide library of the invention and (b) harvesting AAV library particles from the supernatant and/or cell lysates. Finally, AAV vectors obtained by said method are described which are useful for gene therapy, e.g., AAV vectors targeting primary human coronary artery endothelial cells which are suitable for the treatment of diseases associated with a dysfunction of said cells.
AB - Described is a method of producing a repertoire of random peptides on the surface of AAV particles wherein said random peptides are expressed as a fusion with an AAV capsid protein of an AAV particle which displays at its surface said random polypeptides. Also described is a peptide library obtainable by said method as well as a method of selecting a gene therapy vector specific for a desired cell type comprising the steps of (a) infecting the desired cell type with a peptide library of the invention and (b) harvesting AAV library particles from the supernatant and/or cell lysates. Finally, AAV vectors obtained by said method are described which are useful for gene therapy, e.g., AAV vectors targeting primary human coronary artery endothelial cells which are suitable for the treatment of diseases associated with a dysfunction of said cells.
KW - Chemistry
UR - https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2004083441
M3 - Patent
M1 - WO 2004083441
Y2 - 2004/03/19
PB - WIPO - Weltorganisation für geistiges Eigentum
ER -